Home
Charting
e-Prescribing
Labs
Scheduling
Messaging
Documents
Reporting
Billing
 
» April 5, 2011
Founders Fund Leads $23 Million Practice Fusion Financing Round - more
» March 8, 2011
3 in 4 Patients Say Computers Help Doctors Deliver Better Care - more
 
  David Wyatt, MD
Lynn McCallum, MD
Ken Harrington, PM
Raymond Zakhari, NP
 
Home Search Contact Us

HR Meaningful Use Criteria

What is Meaningful Use
Meaningful Use refers to a set of 15 criteria that medical providers must meet in order to prove that they are using their EMR as an effective tool in their practice. There are 10 additional criteria that are considered a la carte menu items, from which only five need to be demonstrated by the medical provider. In total, each provider must complete 20 Meaningful Use criteria—listed in detail below—to qualify for stimulus payments during stage one of the EHR incentive program. The criteria are established by the ONC with public input. Practice Fusion participates in the process to determine criteria.

Stages
Meaningful Use will be measured in stages over five years. Each stage represents a level of adoption. Many HHS-certified EMR systems will allow providers to complete all Meaningful Use criteria. Although, some health IT vendors may choose to only be certified for certain criteria. Practice Fusion will be certified for all 20 criteria – physicians won't need to work with any additional vendors in order to qualify for EMR incentives.

  • Stage One: Essentially, use major functionality of a certified EMR. Document set percentages of your visits, diagnoses, prescriptions, immunizations and other relevant health information electronically; use clinical support tools (warnings and reminders that will be included in certified EMRs); share patient information; and report quality measures and public health information.
  • Stage Two: In addition to continuing to use all functionality from stage 1, physicians will be required to use an EMR to send and receive information such as lab orders and results. Proposed stage 2 criteria are currently out for public comment.
  • Stage Three: Continue fulfilling criteria from stages 1 and 2 plus clinical decisions support for national high priority conditions, enrolling patients in a PHR, accessing comprehensive patient data and improving population health. Stage 3 criteria have not yet been defined in detail.

Mandatory and Menu Meaningful Use Criteria

Core set: All 15 Measures Required

  • Demographics (50%)
  • Vitals: BP and BMI (50%)
  • Problem list:
    ICD-9-CM or SNOWMED (80%)
  • Active medication list (80%)
  • Medication allergies (80%)
  • Smoking status (50%)
  • Patient clinical visit summary
    (50% in 3 days)
  • Hospital discharge instructions (50%)
    - or -
    Patient with electronic copy (50% in 3 days)
  • e-Prescribing (40%)
  • CPOE (30% including a med)
  • Drug-drug and drug-allergy interactions
    (functionality enabled)
  • Exchange critical information
    (perform test)
  • Clinical decision support
    (one rule)
  • Security risk analysis
  • Report clinical quality
    (BP, BMI, Smoke, plus 3 others)

Menu set: Select 5 of 10

  • Drug-formulary checks (one report)
  • Structured lab results (40%)
  • Patients by conditions (one report)
  • Send patient-specific education (10%)
  • Medication reconciliation (50%)
  • Summary care record at transitions (50%)
  • Feed immunization registries
    (perform at least one test)
  • Hospital Advance medical directives
    (50% > 65yrs.)
  • Send reminders to patients for preventative and follow-up care (20% > 65yrs. < 5yrs.)
  • Patient electronic access to labs, problems, meds and allergies (10% in 4 days)

This EHR Module is 2011/2012 compliant and has been certified by an ONC-ATCB in accordance with the applicable certification criteria adopted by the Secretary of Health and Human Services. This certification does not represent an endorsement by the U.S. Department of Health and Human Services or guarantee the receipt of incentive payments. Practice Fusion was certified October 18, 2010, Certification ID number 10182010-9527-1, for Clinical Quality Measures: 170.302 (c), 170.302 (d) 170.302 (e), 170.302 (f)(1), 170.302 (f)(2), 170.302 (f)(3) 170.302 (o), 170.302 (p), 170.302 (q), 170.302 (r), 170.302 (s), 170.302 (t), 170.302 (u), 170.302 (v), 170.304 (b)